By Darius Helm The sustainability movement’s drive toward transparency over the last decade has greatly expanded the scope of sustainability, with both a deeper dive into the material use phase and a longer reach upstream into the supply chain and downstream toward end-of-life or cradle-to-cradle reuse. The focus on greener chemistries has heavily influenced the flooring industry’s evolution, and greener building materials in general have helped drive the growth of models for health and wellness, expressed through organizations like the International Living Future Institute, the International Well Building Institute and the Healthy Building Network. But most of the real work lies ahead.
Thursday, January 14, 2021
On January 8, 2021, the U.S. Environmental Protection Agency (EPA) released the final risk evaluation for 1,4-dioxane. 86 Fed. Reg. 1495. The final risk evaluation identifies unreasonable risk to workers for 13 out of 24 conditions of use. EPA states that it found no unreasonable risk to the general population and the environment. EPA notes that it also published a supplemental analysis to the draft risk evaluation that evaluated eight additional conditions of use for 1,4-dioxane present as a byproduct in consumer products. According to EPA, after “carefully considering” public comments on the supplemental analysis, it found no unreasonable risk for these consumer uses.
To embed, copy and paste the code into your website or blog:
On December 23, 2020, the U.S. Environmental Protection Agency (EPA) released the final risk evaluation for N-methylpyrrolidone (NMP). Of the 37 conditions of use that EPA reviewed, EPA found that 26 present unreasonable risks to workers and consumers. These uses include an unreasonable risk to workers when domestically manufacturing or importing NMP, processing NMP for a variety of uses, and when used in a variety of industrial and commercial conditions of use. These uses also include an unreasonable risk to consumers from one consumer use. EPA found that NMP does not pose an unreasonable risk when distributed in commerce or in a variety of industrial and commercial and consumer applications. EPA also determined that NMP does not present an unreasonable risk to the environment and the general population.
Tuesday, December 29, 2020
On December 23, 2020, the U.S. Environmental Protection Agency (EPA) released the final risk evaluation for N-methylpyrrolidone (NMP). Of the 37 conditions of use that EPA reviewed, EPA found that 26 present unreasonable risks to workers and consumers. These uses include an unreasonable risk to workers when domestically manufacturing or importing NMP, processing NMP for a variety of uses, and when used in a variety of industrial and commercial conditions of use. These uses also include an unreasonable risk to consumers from one consumer use. EPA found that NMP does not pose an unreasonable risk when distributed in commerce or in a variety of industrial and commercial and consumer applications. EPA also determined that NMP does not present an unreasonable risk to the environment and the general population.
Press release content from Business Wire. The AP news staff was not involved in its creation.
In a Major Victory for Public Health, Federal Court Orders EPA to Require Industry to Report on Asbestos Imports and Uses
December 22, 2020 GMT
WASHINGTON (BUSINESS WIRE) Dec 22, 2020
The Asbestos Disease Awareness Organization (ADAO), an independent nonprofit dedicated to preventing asbestos exposure, applauds District Court Judge Edward J. Chen’s decisive ruling today compelling the Environmental Protection Agency (EPA) to require reporting by companies importing and using asbestos under the Toxic Substances Control Act (TSCA).
ADVERTISEMENT
Judge Chen’s extensive opinion sides with ADAO in its legal challenge to EPA’s 2018 denial of its petition to include asbestos in EPA’s Chemical Data Reporting (CDR) rule.